Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

NCT01790308 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: CSII
DRUG: Liraglutide

Sponsor

Sun Yat-sen University